Medipeel, the professional derma aesthetic brand, is accelerating its European push with new launches in France and the UK, building on momentum in the United States, Japan, and Southeast Asia. The brand is positioning itself as a premium K Derma player across Europe, backed by EU CPNP compliance and a network of global retail partnerships.
Printemps’ debut cements premium positioning in France
In Western Europe, Medipeel has strengthened its presence with official debuts at two Printemps stores in France. The brand is now preparing for its launch at the iconic Printemps Haussmann flagship in Paris, long seen as a benchmark for French luxury and a leading influence in European beauty trends, while the Brest location will act as a strategic base for nationwide expansion.
These rollouts follow a highly successful atrium pop up at Printemps Haussmann during July and August, where Medipeel ranked No. 2 overall and No. 1 in skincare, leaving a strong impression on local shoppers. Hero products, including the Red Lacto Collagen Wrapping Mask and Young Cica PDRN line, emerged as clear favorites, highlighting the brand’s focus on advanced actives and K-derma sensibility.
Through the full Printemps launch, Medipeel plans to showcase its signature ranges, from neck creams to peptide eye creams and eye patches, alongside a phased rollout at Korean Cosmetics stores across France. This combination of department store visibility and specialty K beauty distribution is designed to build both prestige and depth in the market.
UK “Science in Red” launch targets 400 influencers
To boost awareness in the UK, Medipeel is staging a major global launch activation in London under the banner “Medipeel UK Launch Event, Science in Red.” The hybrid online offline campaign is being developed in partnership with GlamTouch, a premium K-beauty select shop located in the heart of Bloomsbury, which offers local consumers a direct, immersive introduction to Korean skincare.
The event will center around an in store pop-up and hands on product demos, with around 400 influencers from the UK and across Europe invited to amplify the brand story on social platforms. A “Medipeel Lab Passport” program and QR code activations will encourage attendees and shoppers to trial products and complete online purchases, tightening the connection between physical experience and digital conversion.
A Medipeel representative said the official Printemps entry, combined with the UK launch event, marks “a pivotal moment” as the brand strengthens its foothold in Europe and moves closer to its goal of becoming a global premium K-derma name.
Backed by SKINIDEA and Morgan Stanley PE Asia
Behind the scenes, Medipeel sits as the flagship brand of SKINIDEA, under MDP Holdings (CEO Michael Chung), a portfolio company of Morgan Stanley PE Asia (MSPEA). SKINIDEA is recognized for integrating premium ingredients with patented dermatological technologies, exporting to over 75 countries worldwide and developing high performance skincare through extensive research and clinical trials.
This structure allows Medipeel to combine professional grade innovation with global scalability, delivering both immediate and long term benefits tailored to diverse skin types as it expands further into Europe and beyond.
